RENA ABRAHAM: Open Payments
NPI 1558947994 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 51 payments from 14 companies in 2025. Trend: 2023 $1,293 · 2024 $1,496 · 2025 $1,069
Food & beverage: $989Education: $80
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $280 |
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| ABBVIE INC. | 5 | $97 |
| Lilly USA, LLC | 5 | $76 |
| GENZYME CORPORATION | 2 | $63 |
| UCB, Inc. | 3 | $62 |
| Galderma Laboratories, L.P. | 4 | $61 |
| Amgen Inc. | 3 | $60 |
| Janssen Biotech, Inc. | 3 | $60 |
| PFIZER INC. | 2 | $49 |
Products named: ILUMYA, COSENTYX, DUPIXENT, RINVOQ, Bimzelx, OTEZLA, TREMFYA, EBGLYSS.
Industry payments across TX — which companies pay providers there.
